Prelude Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,500
| Closed | -$508K | – | 1246 |
|
|
2025
Q1 | $508K | Sell |
38,500
-1,336
| -3% | -$17.6K | 0.04% | 446 |
|
|
2024
Q4 | $629K | Sell |
39,836
-16,979
| -30% | -$268K | 0.04% | 423 |
|
|
2024
Q3 | $903K | Buy |
56,815
+315
| +0.6% | +$5.01K | 0.05% | 364 |
|
|
2024
Q2 | $861K | Sell |
56,500
-18,500
| -25% | -$282K | 0.06% | 309 |
|
|
2024
Q1 | $1.1M | Hold |
75,000
| – | – | 0.06% | 337 |
|
|
2023
Q4 | $1.04M | Hold |
75,000
| – | – | 0.07% | 248 |
|
|
2023
Q3 | $1M | Hold |
75,000
| – | – | 0.07% | 251 |
|
|
2023
Q2 | $947K | Hold |
75,000
| – | – | 0.06% | 273 |
|
|
2023
Q1 | $854K | Sell |
75,000
-380
| -0.5% | -$4.33K | 0.05% | 307 |
|
|
2022
Q4 | $780K | Buy |
75,380
+380
| +0.5% | +$3.93K | 0.04% | 389 |
|
|
2022
Q3 | $785K | Buy |
75,000
+18,320
| +32% | +$192K | 0.03% | 483 |
|
|
2022
Q2 | $628K | Sell |
56,680
-18,320
| -24% | -$203K | 0.02% | 577 |
|
|
2022
Q1 | $836K | Buy |
75,000
+24,500
| +49% | +$273K | 0.02% | 514 |
|
|
2021
Q4 | $661K | Sell |
50,500
-15,500
| -23% | -$203K | 0.02% | 653 |
|
|
2021
Q3 | $860K | Hold |
66,000
| – | – | 0.02% | 459 |
|
|
2021
Q2 | $970K | Hold |
66,000
| – | – | 0.03% | 486 |
|
|
2021
Q1 | $810K | Hold |
66,000
| – | – | 0.02% | 428 |
|
|
2020
Q4 | $941K | Hold |
66,000
| – | – | 0.02% | 220 |
|
|
2020
Q3 | $918K | Hold |
66,000
| – | – | 0.04% | 169 |
|
|
2020
Q2 | $700K | Buy |
+66,000
| New | +$700K | 0.04% | 222 |
|